Logo image of SREA

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) Stock Fundamental Analysis

NYSE:SREA - New York Stock Exchange, Inc. - US8168516040 - Currency: USD

21.55  +0.02 (+0.09%)

Fundamental Rating

3

Taking everything into account, SREA scores 3 out of 10 in our fundamental rating. SREA was compared to 25 industry peers in the Multi-Utilities industry. SREA has a medium profitability rating, but doesn't score so well on its financial health evaluation. SREA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SREA had positive earnings in the past year.
SREA had a positive operating cash flow in the past year.
In the past 5 years SREA has always been profitable.
In the past 5 years SREA always reported a positive cash flow from operatings.
SREA Yearly Net Income VS EBIT VS OCF VS FCFSREA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

SREA's Return On Assets of 2.95% is fine compared to the rest of the industry. SREA outperforms 76.00% of its industry peers.
SREA's Return On Equity of 9.23% is in line compared to the rest of the industry. SREA outperforms 52.00% of its industry peers.
SREA has a worse Return On Invested Capital (2.83%) than 92.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SREA is in line with the industry average of 3.93%.
Industry RankSector Rank
ROA 2.95%
ROE 9.23%
ROIC 2.83%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SREA Yearly ROA, ROE, ROICSREA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 21.89%, SREA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SREA has grown nicely.
SREA has a Operating Margin of 22.65%. This is in the better half of the industry: SREA outperforms 68.00% of its industry peers.
In the last couple of years the Operating Margin of SREA has declined.
Industry RankSector Rank
OM 22.65%
PM (TTM) 21.89%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SREA Yearly Profit, Operating, Gross MarginsSREA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SREA is destroying value.
SREA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SREA has been increased compared to 5 years ago.
Compared to 1 year ago, SREA has a worse debt to assets ratio.
SREA Yearly Shares OutstandingSREA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SREA Yearly Total Debt VS Total AssetsSREA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

Based on the Altman-Z score of 0.56, we must say that SREA is in the distress zone and has some risk of bankruptcy.
SREA has a worse Altman-Z score (0.56) than 88.00% of its industry peers.
SREA has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
SREA's Debt to Equity ratio of 1.12 is amongst the best of the industry. SREA outperforms 88.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACC0.58
WACC4.85%
SREA Yearly LT Debt VS Equity VS FCFSREA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

SREA has a Current Ratio of 0.57. This is a bad value and indicates that SREA is not financially healthy enough and could expect problems in meeting its short term obligations.
SREA has a worse Current ratio (0.57) than 84.00% of its industry peers.
A Quick Ratio of 0.51 indicates that SREA may have some problems paying its short term obligations.
SREA has a Quick ratio of 0.51. This is amonst the worse of the industry: SREA underperforms 84.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.51
SREA Yearly Current Assets VS Current LiabilitesSREA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

3

3. Growth

3.1 Past

SREA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.12%.
The Earnings Per Share has been decreasing by -5.31% on average over the past years.
SREA shows a decrease in Revenue. In the last year, the revenue decreased by -3.28%.
SREA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.04% yearly.
EPS 1Y (TTM)5.12%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%7.46%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%4.45%

3.2 Future

SREA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.81% yearly.
Based on estimates for the next years, SREA will show a small growth in Revenue. The Revenue will grow by 2.14% on average per year.
EPS Next Y-1.23%
EPS Next 2Y4.57%
EPS Next 3Y5.83%
EPS Next 5Y6.81%
Revenue Next Year-7.99%
Revenue Next 2Y-1.71%
Revenue Next 3Y0.24%
Revenue Next 5Y2.14%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SREA Yearly Revenue VS EstimatesSREA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SREA Yearly EPS VS EstimatesSREA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.57, the valuation of SREA can be described as very cheap.
SREA's Price/Earnings ratio is rather cheap when compared to the industry. SREA is cheaper than 88.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of SREA to the average of the S&P500 Index (27.41), we can say SREA is valued rather cheaply.
With a Price/Forward Earnings ratio of 4.27, the valuation of SREA can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SREA indicates a rather cheap valuation: SREA is cheaper than 88.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.19. SREA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.57
Fwd PE 4.27
SREA Price Earnings VS Forward Price EarningsSREA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SREA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SREA is cheaper than 68.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.7
SREA Per share dataSREA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.57%
EPS Next 3Y5.83%

More info and screens

3

5. Dividend

5.1 Amount

SREA has a Yearly Dividend Yield of 3.44%. Purely for dividend investing, there may be better candidates out there.
SREA's Dividend Yield is comparable with the industry average which is at 3.73.
Compared to an average S&P500 Dividend Yield of 2.35, SREA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.44%

5.2 History

The dividend of SREA decreases each year by -9.71%.
SREA has been paying a dividend for over 5 years, so it has already some track record.
SREA has decreased its dividend recently.
Dividend Growth(5Y)-9.71%
Div Incr Years0
Div Non Decr Years1
SREA Yearly Dividends per shareSREA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

53.42% of the earnings are spent on dividend by SREA. This is a bit on the high side, but may be sustainable.
DP53.42%
EPS Next 2Y4.57%
EPS Next 3Y5.83%
SREA Yearly Income VS Free CF VS DividendSREA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SREA Dividend Payout.SREA Dividend Payout, showing the Payout Ratio.SREA Dividend Payout.PayoutRetained Earnings

More info and screens

SEMPRA - SRE 5 3/4 07/01/2079

NYSE:SREA (7/14/2025, 11:58:24 AM)

21.55

+0.02 (+0.09%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners90.23%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap14.05B
Analysts73.64
Price Target22.95 (6.5%)
Short Float %0%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield 3.44%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP53.42%
Div Incr Years0
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.359375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.43%
Min EPS beat(2)-7.18%
Max EPS beat(2)8.03%
EPS beat(4)1
Avg EPS beat(4)-5.36%
Min EPS beat(4)-16.27%
Max EPS beat(4)8.03%
EPS beat(8)4
Avg EPS beat(8)-1.23%
EPS beat(12)8
Avg EPS beat(12)2.43%
EPS beat(16)11
Avg EPS beat(16)2.54%
Revenue beat(2)0
Avg Revenue beat(2)-9.28%
Min Revenue beat(2)-14.67%
Max Revenue beat(2)-3.89%
Revenue beat(4)0
Avg Revenue beat(4)-13.33%
Min Revenue beat(4)-22.35%
Max Revenue beat(4)-3.89%
Revenue beat(8)0
Avg Revenue beat(8)-15.32%
Revenue beat(12)3
Avg Revenue beat(12)-3.67%
Revenue beat(16)7
Avg Revenue beat(16)-0.69%
PT rev (1m)2.79%
PT rev (3m)-9.33%
EPS NQ rev (1m)0.73%
EPS NQ rev (3m)5.46%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)0.18%
Revenue NQ rev (1m)-4.74%
Revenue NQ rev (3m)-2.07%
Revenue NY rev (1m)-0.96%
Revenue NY rev (3m)-6.02%
Valuation
Industry RankSector Rank
PE 4.57
Fwd PE 4.27
P/S 1.05
P/FCF N/A
P/OCF 3.1
P/B 0.44
P/tB 0.47
EV/EBITDA 8.7
EPS(TTM)4.72
EY21.9%
EPS(NY)5.05
Fwd EY23.44%
FCF(TTM)-7.76
FCFYN/A
OCF(TTM)6.96
OCFY32.29%
SpS20.47
BVpS48.55
TBVpS45.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.95%
ROE 9.23%
ROCE 3.39%
ROIC 2.83%
ROICexc 2.89%
ROICexgc 2.95%
OM 22.65%
PM (TTM) 21.89%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexcg growth 3Y-8.37%
ROICexcg growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Debt/EBITDA 6.43
Cap/Depr 386.71%
Cap/Sales 71.94%
Interest Coverage 2.57
Cash Conversion 82.42%
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.51
Altman-Z 0.56
F-Score4
WACC4.85%
ROIC/WACC0.58
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.12%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%7.46%
EPS Next Y-1.23%
EPS Next 2Y4.57%
EPS Next 3Y5.83%
EPS Next 5Y6.81%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%4.45%
Revenue Next Year-7.99%
Revenue Next 2Y-1.71%
Revenue Next 3Y0.24%
Revenue Next 5Y2.14%
EBIT growth 1Y1.34%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year60.88%
EBIT Next 3Y22.79%
EBIT Next 5Y14.31%
FCF growth 1Y0.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y199.54%
OCF growth 3Y8.5%
OCF growth 5Y9.71%